KP Tissue Inc. (TSX:KPT) exceeded its forecasted EPS, reporting $0.09 against the expected $0.06.
The company’s revenue of approximately $379.5 million fell short of the anticipated $515.5 million, indicating a gap in sales performance.
Despite the revenue shortfall, a positive EPS and a P/E ratio of 34.75 suggest effective cost management and high market expectations.
KP Tissue Inc. (TSX:KPT), a prominent player in the Canadian tissue product market, known for its popular brands like Cashmere® and Purex®, operates alongside Kruger Products Inc., serving both consumer and Away-From-Home markets. Recently, KPTSF, its U.S. counterpart trading on the PNK exchange, reported its Q1 2025 earnings, revealing mixed financial results.
On May 14, 2025, KPTSF announced an earnings per share (EPS) of $0.09, exceeding the forecasted EPS of $0.06. This indicates a stronger-than-expected profitability for the quarter. However, the company’s revenue of approximately $379.5 million fell short of the anticipated $515.5 million, highlighting a gap in expected sales performance.
During the Q1 2025 earnings call, CEO Dino Bianco and CFO Michael Keays addressed these results. The call, attended by major financial institutions like CIBC Capital Markets and TD Cowen, provided insights into the company’s financial health. Despite the revenue shortfall, the positive EPS suggests effective cost management or other operational efficiencies.
KPTSF’s financial metrics offer further context. With a price-to-earnings (P/E) ratio of 34.75, investors are paying 34.75 times the company’s earnings, indicating high market expectations. The enterprise value to operating cash flow ratio of 24.24 suggests the company is valued at 24.24 times its operating cash flow, reflecting investor confidence in its cash-generating ability.
The company’s current ratio of 1 shows a balanced short-term financial position, with current assets equaling current liabilities. This stability, combined with an earnings yield of 2.88%, provides a comprehensive view of KPTSF’s financial standing, despite the revenue miss.
